127 related articles for article (PubMed ID: 7333038)
1. Evaluation of blood toxicity in chronic uremia by an improved chromatographic method.
Politi L; D'Angelo AR; Caramia M; Molinaro M; Nicoletti R; Cerulli N; Moriggi M; Scandurra R
Clin Exp Dial Apheresis; 1981; 5(3):277-84. PubMed ID: 7333038
[TBL] [Abstract][Full Text] [Related]
2. Analysis of plasma middle molecular fraction in uremic patients.
Kovalishin YaF
Biomater Artif Cells Artif Organs; 1987; 15(3):605-10. PubMed ID: 3440134
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
Ringoir SM; van Landschoot N; de Smet R
Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
[TBL] [Abstract][Full Text] [Related]
4. Uremic toxins and the elusive middle molecules.
Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
[No Abstract] [Full Text] [Related]
5. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
Popławski A; Myśliwiec M; Soszka J
Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
[TBL] [Abstract][Full Text] [Related]
6. Serum middle molecules in uremia.
Buzio C; Manari A; Calderini C; Montagna G; Migone L
Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
[No Abstract] [Full Text] [Related]
7. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
Kovalishin IaF; Nikolaev VG; Baran EIa; Dudar' IA; Iushko LA
Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937
[TBL] [Abstract][Full Text] [Related]
8. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
Popławski A; Myśliwiec M
Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
[No Abstract] [Full Text] [Related]
9. [The anticoagulant activity of the plasma ultrafiltrate as a possible criterion of uremic poisoning].
Sukhanov VA; Chuzhinov SV; Koriakov IO; Zlokazov VB
Ter Arkh; 1991; 63(6):68-71. PubMed ID: 1948752
[No Abstract] [Full Text] [Related]
10. Ion-pair high-performance liquid chromatography profiling of a uremic toxin fraction.
Gallice P; Monti JP; Le Gall JM; Crevat A; Murisasco A
J Chromatogr; 1987 Nov; 422():263-6. PubMed ID: 3437013
[No Abstract] [Full Text] [Related]
11. [Study of toxic activity of blood in uremia].
Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
[No Abstract] [Full Text] [Related]
12. Profiling of uremic ultrafiltrate using high resolution gas chromatography-mass spectrometry - identification of 6 polyphenols.
Niwa T; Maeda K; Ohki T; Saito A; Kobayashi S; Asada H; Kobayashi K
Clin Chim Acta; 1980 Nov; 108(1):113-9. PubMed ID: 7449132
[TBL] [Abstract][Full Text] [Related]
13. Separation of six uremic middle molecular compounds by high performance liquid chromatography and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Chu J; Yuan Z; Liu X; Wu Q; Mi H; He B
Clin Chim Acta; 2001 Sep; 311(2):95-107. PubMed ID: 11566169
[TBL] [Abstract][Full Text] [Related]
14. Quantification of free and protein bound uremic toxins in human serum by LC-MS/MS: Comparison of rapid equilibrium dialysis and ultrafiltration.
Fabresse N; Uteem I; Lamy E; Massy Z; Larabi IA; Alvarez JC
Clin Chim Acta; 2020 Aug; 507():228-235. PubMed ID: 32371217
[TBL] [Abstract][Full Text] [Related]
15. Chemical analytic approaches to the definition of uremic toxins.
Furst P; Bergstrom J; Gordon A; Zimmermann L
Ateneo Parmense Acta Biomed; 1975; 46(5):307-16. PubMed ID: 1232992
[TBL] [Abstract][Full Text] [Related]
16. Analytical study for separation of middle molecules.
Saito A; Kanazawa I; Chung TG; Maeda K
Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
[TBL] [Abstract][Full Text] [Related]
17. Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.
Mingrone G; De Smet R; Greco AV; Bertuzzi A; Gandolfi A; Ringoir S; Vanholder R
Clin Chim Acta; 1997 Apr; 260(1):27-34. PubMed ID: 9101098
[TBL] [Abstract][Full Text] [Related]
18. Uremic middle molecules exist and are biologically active.
Bergström J; Fürst P; Zimmerman L
Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
[No Abstract] [Full Text] [Related]
19. [Isolation, structure elucidation and synthesis of a hexapeptide from the hemodialysate of uremic patients].
Bovermann G; Rautenstrauch H; Seybold G; Jung G
Hoppe Seylers Z Physiol Chem; 1982 Oct; 363(10):1187-202. PubMed ID: 7141402
[TBL] [Abstract][Full Text] [Related]
20. [Biochemical definition of uremia].
Ringoir S
Verh K Acad Geneeskd Belg; 1981; 43(2):105-19. PubMed ID: 7314875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
